Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/14/2000US6146891 Methods for cultivating cells and propagating viruses
11/14/2000US6146889 Proliferation of hepatocyte precursors
11/14/2000US6146888 Amplification of preferential cell population; mixing cells in which the genome codes an antibiotic resistance gene, recovering cells that propagate in the presence of antibiotic
11/14/2000US6146887 DNA expression vectors for use in the gene therapeutic treatment of vascular disorders
11/14/2000US6146886 RNA polymerase III-based expression of therapeutic RNAs
11/14/2000US6146885 Plasmid for transfer of genes into vertebrate cells
11/14/2000US6146877 Identification of the progression elevated gene-3 and uses thereof
11/14/2000US6146876 22025, a novel human cyclic nucleotide phosphodiesterase
11/14/2000US6146874 Method of preparing recombinant adeno-associated virus compositions
11/14/2000US6146871 Process for modifying the enzyme 7β-(4-carboxybutanamide) cephalosporinacylase and purifying said enzyme in a single chromatographic step
11/14/2000US6146870 Flea protease proteins
11/14/2000US6146869 Nucleotide and amino acid sequence of aspergillus enzyme
11/14/2000US6146868 Nucleotide and amino acid sequence of enzyme which deacetylates component of fungal capsule; fungicides for treatment of cryptococcosis
11/14/2000US6146867 Methods for expressing a maize acetyl CoA carboxylase gene in host cells and encoded protein produced thereby
11/14/2000US6146866 Lumazine synthase and riboflavin synthase
11/14/2000US6146864 Nucleotide and amino acid sequence from fusarium venenatum; for recombinant production of enzyme
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146862 Thermostable diaphorase gene
11/14/2000US6146854 Filtration processes, kits and devices for isolating plasmids
11/14/2000US6146852 Production of human parathyroid hormone from microorganisms
11/14/2000US6146851 DNA encoding NV2 (long form) and carboxy truncated fragments thereof
11/14/2000US6146850 Proteins encoding gelonin sequences
11/14/2000US6146849 Recombinant dna which codes for a mature calcium-dependent lectin having a defined amino acid sequence; for recombinant production
11/14/2000US6146848 Bacterial expression system
11/14/2000US6146847 Stabilized transient gene expression
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
11/14/2000US6146841 Methods for identifying compounds that bind to CSAPK-3 molecules and fragments thereof
11/14/2000US6146835 Nucleotide sequence; for drug screening of novel analgesics; for recombinant production of receptor
11/14/2000US6146832 Protein kinase molecules and uses therefor
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146829 Gapped 2' modified oligonucleotides
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146826 Green fluorescent protein
11/14/2000US6146643 A hepatitis a virus having a genome consisting of a human attenuated hepatitis a virus sequence wherein the 5' noncoding region has been replaced by the 5' noncoding region of simian hepatitis a virus agm-27
11/14/2000US6146642 Recombinant new castle disease virus RNA expression systems and vaccines
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146631 Administering a fusion protein comprising a gelonin prefered amino acid sequeance, a targeting sequence that allows internalization of fusion protein in the cell, internizing the fusion protein in the cell, eliminating the cell
11/14/2000US6146624 Human ubiquitin-conjugating enzymes
11/14/2000US6146511 Electrophoretic nucleic acid purification method
11/14/2000CA2188933C Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/14/2000CA2153103C Process for lysing mycobacteria
11/14/2000CA2074839C Modified factor vii anticoagulant proteins
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/10/2000CA2270636A1 Animal embryo commercial production by using in vitro fertilization technology
11/09/2000WO2000067028A1 Process to create biomolecule arrays on metal surfaces
11/09/2000WO2000067016A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066789A2 Polynucleotide matrix-based method of identifying microorganisms
11/09/2000WO2000066788A2 Polynucleotide probes for detection and quantitation of staphylococcus
11/09/2000WO2000066786A2 Polynucleotide probes for detection and quantitation of actinomycetes
11/09/2000WO2000066783A2 Rapid and efficient capture of dna from sample without using cell lysing reagent
11/09/2000WO2000066780A2 Adeno-associated virus-delivered ribozyme compositions and methods of use
11/09/2000WO2000066777A2 Assay based on the analysis of dna melting curves
11/09/2000WO2000066774A2 Improved assay and reagents therefor
11/09/2000WO2000066773A2 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents
11/09/2000WO2000066771A2 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry
11/09/2000WO2000066768A1 Method of amplification of nucleic acids
11/09/2000WO2000066766A1 Optical probes and assays
11/09/2000WO2000066762A2 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
11/09/2000WO2000066759A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/09/2000WO2000066758A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000WO2000066757A1 Cloned and engineered plants and methods of use for bioremediation
11/09/2000WO2000066756A1 Microbial protein expression system
11/09/2000WO2000066755A2 Pesticidal fusions
11/09/2000WO2000066754A1 Protein c derivatives
11/09/2000WO2000066753A2 Modified vitamin k-dependent polypeptides
11/09/2000WO2000066752A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide
11/09/2000WO2000066751A1 Expression cassette for efficient production of a protein
11/09/2000WO2000066750A2 Methods for producing plants with elevated oleic acid content
11/09/2000WO2000066749A1 Plant acyltransferases
11/09/2000WO2000066748A1 Herbicide resistant plants
11/09/2000WO2000066747A1 Herbicide resistant plants
11/09/2000WO2000066746A1 Herbicide resistant plants
11/09/2000WO2000066745A1 Novel genes encoding wheat starch synthases and uses therefor
11/09/2000WO2000066744A1 Glucose dehydrogenase
11/09/2000WO2000066743A2 Viral expression vectors
11/09/2000WO2000066742A2 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants
11/09/2000WO2000066741A2 Conserved neisserial antigens
11/09/2000WO2000066740A1 Flagellin peptides and receptors
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066738A1 Process for producing recombinant insulin from novel fused protein
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066734A1 Methods of treating hypertension
11/09/2000WO2000066733A1 Protein specific for cardiac and skeletal muscle
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066729A1 Meg-3 protein
11/09/2000WO2000066728A1 StAR HOMOLOGUES
11/09/2000WO2000066727A1 Tumour-associated antigen
11/09/2000WO2000066726A1 Novel cellular regulation factor tto 20
11/09/2000WO2000066725A1 Use of inducible no-synthase antisense oligonucleotides for preventing and treating cerebral ischemia
11/09/2000WO2000066724A2 Oligonucleotide derivatives directed against human bcl-xl and human bcl-2 mrna
11/09/2000WO2000066723A1 Method of ultrafiltration
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
1 ... 3157 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 ... 4023